Avelox 400 mg/250 ml sol. perf. i.v. flac. Բելգիա - ֆրանսերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

avelox 400 mg/250 ml sol. perf. i.v. flac.

bayer sa-nv - chlorhydrate de moxifloxacine 1,75 mg/ml - eq. moxifloxacine 1,6 mg/ml - solution pour perfusion - moxifloxacin

Avelox 400 mg film-coated tablets Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

avelox 400 mg film-coated tablets

bayer limited - moxifloxacin - film-coated tablet - 400 milligram(s) - fluoroquinolones; moxifloxacin

AVELOX 400/250 Mg/Ml Solution for Infusion Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

avelox 400/250 mg/ml solution for infusion

bayer limited - moxifloxacin hydrochloride - solution for infusion - 400/250 mg/ml - fluoroquinolones

Avelox 400 mg/250 ml solution for infusion Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

avelox 400 mg/250 ml solution for infusion

bayer limited - moxifloxacin hydrochloride - solution for infusion - 400 mg /250 millilitre(s) - fluoroquinolones; moxifloxacin

Avelox 400mg film-coated Tablets Մալթա - անգլերեն - Malta Medicines Authority

avelox 400mg film-coated tablets

bayer public limited company - moxifloxacin - film-coated tablet - moxifloxacin 400 milligram(s) - antibacterials for systemic use

Avelox 400mg/250ml solution for infusion Մալթա - անգլերեն - Malta Medicines Authority

avelox 400mg/250ml solution for infusion

bayer public limited company - moxifloxacin - solution for infusion - moxifloxacin 400 milligram(s) - antibacterials for systemic use

AVELOX 400 Milligram Film Coated Tablet Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

avelox 400 milligram film coated tablet

ltt pharma limited - moxifloxacin hydrochloride - film coated tablet - 400 milligram - fluoroquinolones - quinolone antibacterials, fluoroquinolones - it is indicated for the treatment of the following bacterial infections in patients of 18 years and older caused by bacteria susceptible to moxifloxacin: - acute bacterial sinusitis (adequately diagnosed) - acute exacerbations of chronic bronchitis (adequately diagnosed) - community acquired pneumonia, except severe cases - mild to moderate pelvic inflammatory disease (i.e. infections of female upper genital tract, including salpingitis and endometritis), without an associated tubo-ovarian or pelvic abscess. it may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous moxifloxacin for the following indications: - community-acquired pneumonia - complicated skin and skin structure infections

AVELOX Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

avelox

lexon (uk) ltd - moxifloxacin hydrochloride - film coated tablet - 400 milligram - moxifloxacin

Avelox 400mg tablets Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

avelox 400mg tablets

bayer plc - moxifloxacin hydrochloride - oral tablet - 400mg

Avelox 400mg/250ml solution for infusion bottles Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

avelox 400mg/250ml solution for infusion bottles

bayer plc - moxifloxacin hydrochloride - solution for infusion - 1.6mg/1ml